The Case For Using Novel Value Elements When Assessing COVID-19 Vaccines And Therapeutics
Health Affairs
Authors
Sachin Kamal-Bahl, Richard Willke, Justin T. Puckett, Jalpa A. Doshi
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
"Do not inject our babies": a social listening analysis of public opinion about authorizing pediatric COVID-19 vaccines
Health Affairs ScholarJuly 8, 2024 -
Megastudy shows that reminders boost vaccination but adding free rides does not
NatureJune 26, 2024 -
Psychosocial correlates of parents' willingness to vaccinate their children against COVID-19
PLOS OneJune 24, 2024 -
Engaging Trusted Messengers to Increase COVID-19 Pediatric Vaccine Uptake in Philadelphia: Lessons from the VaxUpPhillyFamilies program
Science DirectJune 8, 2024 -
Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans
JAMA NetworkJune 6, 2024 -
Validation of a smartphone telematics algorithm for classifying driver trips
Science DirectMay 17, 2024 -
How Can a Behavioral Economics Lens Contribute to Implementation Science?
Implementation ScienceApril 26, 2024 -
Association Between the SaFETy Score and Self-reported Firearm Violence Among Young Adults Presenting to Emergency Departments in Three Cities: A Cross-Sectional Study
Annals of Internal MedicineApril 23, 2024 -
Friends with Health Benefits: A Field Experiment
Management ScienceApril 17, 2024 -
Co-Designing Strategies To Implement Long-Acting Injectable PrEP for Sexual Minority Men in Chicago: A Study Protocol for an Innovation Tournament and Implementation Mapping
Implementation Science CommunicationsMarch 25, 2024 -
Adolescent Preferences for a Pediatric Primary Care-Based Sexually Transmitted Infection and HIV Prevention Intervention
Journal of Adolescent HealthMarch 24, 2024 -
Measuring Quality-Weighted Hospital-Free-Days in Acute Respiratory Failure: A Modified Delphi Study
Annals of the American Thoracic SocietyMarch 20, 2024